Results 101 to 110 of about 6,848,720 (280)
Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics [PDF]
PURPOSE OF REVIEW: Common variable immunodeficiency represents the largest group of primary immunodeficiency patients. The variable clinical manifestations include an increased susceptibility to chronic infections, granulomatous disease and the ...
Bodo Grimbacher +2 more
core +1 more source
FBL directly binds to and stabilizes SIRT1 by blocking its ubiquitin‐proteasome degradation, thereby sustaining nicotinamide metabolism and redox homeostasis to counteract cellular senescence in ESCC. Genetic and pharmacological suppression of FBL sensitizes tumor cells to senolytic therapy.
Xing Jin +9 more
wiley +1 more source
Common Variable Immunodeficiency (CVI) 1례
Common variable immunodeficiency is a heterogeneous group of disorders characterized by hypogammaglobulinemia, impaired antibody response and recurrent bacterial infections. Although it is represented by an acquired defect of humoral immunity, cellular
Ahn, Hyo Sup +6 more
core
GC cells enhance glutamine accumulation by upregulating SLC1A5 expression. This upregulation not only boosts GC cell proliferation, but also outcompetes CD8+ T cells for glutamine and suppresses their antitumor immunity. Mechanistically, METTL7A deficiency in GC induces SLC1A5 overexpression via an m6A‐dependent pathway and N‐glycosylation ...
Mingjun Sun +16 more
wiley +1 more source
Migratory pneumonia caused by common variable immunodeficiency disorder
Recurrent respiratory infections are important causes for bronchiectasis which can also be caused by a severe or poorly treated single infective event.
Maged Hassan
doaj +1 more source
This study shows that a PARP inhibitor combined with anlotinib, administered as bridging therapy, preconditions the tumor microenvironment to enhance the infiltration and antitumor activity of subsequently infused CAR‐T cells across preclinical ovarian cancer models, supporting bridging therapy as a promising strategy to address limited CAR‐T cell ...
Huayi Li +20 more
wiley +1 more source
Common variable immunodeficiency (CVID) is one of the predominant antibody deficiencies and the most common symptomatic inborn error of immunity (IEI). However, in most cases, the genetic background of the disease cannot be identified.
Ümmügülsüm Dikici +2 more
core +1 more source
Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy
By engineering a receptor system integrating the plant auxin receptor AFB1 with its co‐receptor IAA7, we enable ligand‐dependent interactions triggered by the plant hormone auxins. This design allows rapid, reversible, and dose‐dependent T cell activation, resulting in potent cytotoxicity against B‐cell lymphoma in vitro and in vivo.
Hongxiang Zeng +16 more
wiley +1 more source
Infections in 252 patients with common variable immunodeficiency. [PDF]
International audienceBACKGROUND: Common variable immunodeficiency is characterized by recurrent infections and defective immunoglobulin production.
Gael Mouillot +37 more
core +1 more source
CircZNF148 stabilizes HK1 through deubiquitinase recruitment, thereby enhancing glycolysis and lactate production. Elevated lactate promotes PD‑L1 lactylation and membrane accumulation while suppressing CD8+ T‐cell cytotoxicity, collectively facilitating immune evasion and malignant progression in TNBC.
Yuhan Jin +17 more
wiley +1 more source

